Ishita Drugs (524400)
STALWARTScore breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹72.57 |
| Market Cap | ₹22.48 Cr |
| P/E Ratio | 23.84 |
| ROCE | 9.91% |
| ROE | 8.66% |
| Dividend Yield | 0% |
| Profit Growth | -33.33% |
| Debt/Equity | — |
| Sales Growth | -23.97% |
| 52-Week Range | ₹66 — ₹90.85 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹36.03 |
Ishita Drugs trades with a P/E ratio of 23.84, ROCE of 9.91%, ROE of 8.66%, profit growth of -33.33%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer